EU GMP Annex 1 and Pharmig’s response (pre-recorded) – FREE WEBINAR
View FREE a recorded webinar led by Dr Tim Sandle (BPL) on EU GMP Annex 1 and Pharmig’s responses
In December 2017 a new draft of EU GMP Annex 1 was issued for public comment. Pharmig was one of the organisations that responded, following consultation with members.
This webinar (which was run and recorded in May 2018) is an opportunity to learn about the key changes to Annex 1 and to hear about Pharmig’s consolidated responses.
This webinar will:
- Introduce EU GMP Annex
- Review the key changes, which include:
- Greater emphasis upon Quality Risk Management
- Requirement for a holistic contamination control strategy
- Acknowledgement of improvements to sterile processing technology, such as barrier systems
- Expansion of the scope to provide guidance for non-sterile manufacturing
- The main points raised by Pharmig members
Please do click on the link below to register for the FREE recorded webinar